Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Arbutus Biopharma ( (ABUS) ).
Michael J. Sofia is set to retire as the Chief Scientific Officer of Arbutus Biopharma, Inc. by the end of 2024, and an amendment to his employment agreement has been made regarding his retirement benefits and post-retirement activities. The amendment ensures that Dr. Sofia will receive his annual bonus for 2024 and clarifies the scope of activities he can engage in after retirement, in line with his non-compete obligations.
See more insights into ABUS stock on TipRanks’ Stock Analysis page.